Valeant CEO Meets With Top Execs After Medical Leave

The video discusses a company's internal messaging and meetings with top executives, highlighting a positive internal outlook despite public skepticism. It covers the lack of external communication, the SEC investigation, and upcoming financial updates. The board's investigation into a controversial pharmacy relationship is also addressed, along with recent board changes and debt management strategies, including the potential sale of Bausch and Lomb.

What changes are being made to the board, and why are they significant?

What suggestions were made regarding the company's debt management?